Atlas Trials

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

Clinical trial NCT03404856 · UNKNOWN

Trial details

NCT number
NCT03404856
Sponsor
Orpha Labs
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Glycogen Storage Disease, Type 14
Start date
2017-10-31
Primary completion
2019-10-31
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.